TRICARE is the military health benefit covering service members, retirees, and their families. Coverage practices are set by TRICARE's pharmacy and therapeutics committee.
Type 2 diabetes coverage
Covered for T2D. Typical copay $0–$15/month for retail prescriptions.
Weight management coverage
Variable. TRICARE has expanded coverage of Wegovy and Zepbound under specific criteria but remains restrictive.
Cardiovascular indication coverage
Coverage of Wegovy under March 2024 CV indication expanding.
OSA indication coverage
Coverage of Zepbound for OSA expanding.
Prior authorization criteria (typical)
TRICARE PA criteria are similar to commercial: BMI thresholds, comorbidity, documented lifestyle modification.
If your plan excludes weight-management drugs
Active duty service members should consult military treatment facility; retirees can verify with TRICARE customer service.
How to verify
The most reliable way to verify coverage is to call the member services number on your insurance card and ask: (1) Is [Wegovy/Zepbound/Ozempic/Mounjaro] on my formulary? (2) What tier? (3) What are the prior authorization criteria? (4) What's my expected copay at each tier? Document the date, the rep's name, and any reference number.
Cash-pay alternative
If insurance coverage is unworkable, see our price index for current cash-pay compounded options. NexLife, our editorial pick, lists compounded semaglutide at $95–$109 and tirzepatide at $115–$129 a month depending on plan length (prices as of November 6, 2026); see the NexLife review.